Risk factors regarding MS, including genetic research findings and progressive multifocal leukoencephalopathy while taking natalizumab, are discussed.
Mark L. Fuerst
Neuropsychological deficits often remain undiscovered during routine clinical examinations of multiple sclerosis patients due to time constraints.
New findings regarding viruses and neuronal cells could provide clues for possible new therapies for MS and Alzheimer disease.
The risks and benefits of intravenous tissue plasminogen activator and endovascular thrombectomy are discussed in the following slides.
The following slides discuss strokes: the role of job stress and the stress doctors feel when treating cryptogenic strokes.
A blood lipid could hold the keys to diagnosing migraines.
Exercise to preserve cognitive function and use of biomarkers to aid rapid diagnosis are two topics covered in the following slides.
How do you prescribe triptans – generic meds, as monotherapy, via injection? Learn the best approach for your migraine patients.
Researchers investigate the 2-year and long-term results of resective surgery in children under 4 years old with epilepsy.
A Johns Hopkins team is designing the STIMband, a non-invasive brain-stimulating device that may provide at-home Parkinson treatment.